Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexacerfont in women with D-IBS
NCT00399438Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pexacerfont in Irritable bowel syndrome with diarrhea (IBS-D) (3 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Gastrointestinal Transit (Radioscintigraphy). Started Dec 2006; status: completed.
02
Drugs
pexacerfont
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00399438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399438.